Six hours after work in an empty, non-ventilated silo a 27-year-old Yugoslav worker suffered acutely from cough, dyspnea and general weakness. He was admitted to the hospital with severe partial respiratory insufficiency, and after emergency intubation artificial respiration had to be installed. X-ray showed a severe symmetrical alveolo-interstitial opacity. The heart configuration was normal. History revealed that the neighbouring silo had been filled with green corn the day before. Both silos were connected by a common drain-wall. Furthermore, a yellowish discolouration of the new paint in the empty silo was noted. Based on these facts silo-filler's disease was diagnosed. The patient recovered rapidly under high doses of steroids. Lung function was normalized within nine days, and the patient was released from the hospital. Steroid therapy was continued for six weeks.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial.
BMJ Open Respir Res
January 2025
Lane Fox Clinical Respiratory Physiology Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Introduction: Patients recovering from severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have a 30-day readmission rate of 20%. This study evaluated the feasibility of conducting a randomised controlled trial to evaluate clinical, patient-reported and physiological effects of home high-flow therapy (HFT) in addition to usual medical therapy, in eucapnic patients recovering from AECOPD to support the design of a phase 3 trial.
Methods: A mixed-methods feasibility randomised controlled trial (quantitative primacy, concurrently embedded qualitative evaluation) (ISRCTN15949009) recruiting consecutive non-obese patients hospitalised with AECOPD not requiring acute non-invasive ventilation.
Remarkable Response to Dabrafenib and Trametinib in a V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) V600E-Mutated Lung Adenocarcinoma Patient With Poor Performance Status and Respiratory Failure: A Case Report.
Cureus
December 2024
Division of Respiratory Medicine, Yuuai Medical Center, Okinawa, JPN.
Article Synopsis
- A 73-year-old man with worsening shortness of breath and respiratory failure was diagnosed with primary lung adenocarcinoma featuring the BRAF V600E mutation after imaging and biopsy.
- He started treatment with a combination of dabrafenib and trametinib, which led to significant clinical and radiological improvements while being well-tolerated despite his critical condition.
- This case highlights the potential effectiveness and safety of targeted therapies for patients with serious health challenges, such as acute respiratory failure and poor performance status, in the context of BRAF V600E mutated non-small cell lung cancer.
High Altitude Pulmonary Edema Associated with Climbing Mount Fuji: A Case Report.
Intern Med
January 2025
Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Japan.
A 51-year-old man presented to the emergency department with rapidly progressive dyspnea that developed while climbing Mount Fuji. He had climbed Mount Fuji twice without experiencing similar symptoms. On arrival, his oxygen saturation was 91% on 10 L/min of oxygen with a non-rebreather mask.
View Article and Find Full Text PDFDiagnostic Application of Bronchoalveolar Lavage Fluid Analysis in Cases of Idiopathic Pulmonary Fibrosis in which Diagnosis Cannot Be Confirmed by High-Resolution Computed Tomography.
Lung
January 2025
Department of Respiratory Medicine, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
Purpose: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic lung disorder characterized by dry cough, fatigue, and exacerbated dyspnea. The prognosis of IPF is notably unfavorable, becoming extremely poor when the disease advances acutely. Effective therapeutic intervention is essential to mitigate disease progression; hence, early diagnosis and treatment are paramount.
View Article and Find Full Text PDFAcute ST-elevation myocardial infarction (STEMI) is a life-threatening condition often associated with significant cardiac complications, particularly in the presence of underlying multivessel coronary artery disease. Mechanical complications, such as acute mitral regurgitation (MR), can worsen the clinical course, leading to rapid hemodynamic deterioration. Recent advancements in mechanical circulatory support and percutaneous interventions have introduced new therapeutic options, offering viable alternatives to traditional surgery for high-risk patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!